Coca-Cola Could Make A Move Into CBD-Infused Drinks

Coca-Cola Could Make A Move Into CBD-Infused Drinks

Coca-Cola Could Make A Move Into CBD-Infused Drinks

While Coca-Cola declined to comment on the Aurora deal, spokesperson Kent Landers told BNN Bloomberg that "along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world".

Coca-Cola announced its interest in a statement on Monday, responding to a report from BNN Bloomberg that said it was in talks with Canada's Aurora Cannabis Inc to develop drinks infused with cannabidiol (CBD), the non-psychoactive chemical found in marijuana.

"The space is evolving quickly", Coca-Cola said.

This isn't the first time Coca-Cola expressed interest in CBD and cannabis. "However, we have a responsibility to our shareholders to give proper consideration to all relevant opportunities that are presented", said Heather MacGregor from the Aurora. "Stories like this are further validation of the massive global potential of the cannabis industry".

More news: Apple's cheaper iPhone XR rocks bright colours

In addition, a number of Canadian cannabis companies, including Cronos and MedMen Enterprises, now trade on USA stock exchanges, and some American companies have taken stakes.

Spirits maker Constellation Brands bought a minority stake in a Canadian marijuana producer past year.

Coke's possible foray into the marijuana sector comes as beverage makers are trying to add cannabis as a trendy ingredient while their traditional businesses slow. Heineken's Lagunitas craft-brewing label has launched a brand specializing in non-alcoholic drinks infused with THC, marijuana's active ingredient. Just last week, Coke announced a deal to buy Costa Coffee for $5 billion. The drug is still illegal under U.S. federal law, although some states have decriminalized it. The Edmonton, Alberta-based company has soared along with other pot stocks in Canada as the country gears up to become the first Group of Seven nation to legalize cannabis on October 17.

In June, the US Food and Drug Administration approved the epilepsy treatment Epidiolex, the first cannabis-based drug allowed in the United States.

Related news